Isotretinoin: Scientific Profile
Publicado el · Actualizado el
Systemic retinoid for research, classified as 13-cis-retinoic acid. It acts as an agonist of the nuclear receptors RAR and RXR, modulating sebaceous activity and cell differentiation.
Isotretinoin is a molecule derived from vitamin A that has been the subject of extensive research due to its unique ability to alter the physiology of the pilosebaceous unit. In in vivo experimentation contexts, this compound demonstrates a marked ability to induce apoptosis in sebocytes, which results in a drastic reduction of glandular volume and of cutaneous lipid production. This phenomenon is fundamental to the study of dermatological pathologies characterized by follicular hyperkeratosis.
In addition to its glandular impact, isotretinoin regulates the proliferation of infundibular keratinocytes, preventing the formation of microcomedones in study models. Its administration in research protocols allows a local immunomodulatory response to be observed, decreasing the infiltration of inflammatory mediators in epithelial tissue. Pharmacokinetics in test subjects show high binding to plasma proteins, predominantly albumin, and hepatic metabolism mediated by cytochrome P450.
In the field of molecular biology, its role in gene transcription is investigated through interaction with retinoic acid receptors (RAR) and retinoid X receptors (RXR). These interactions modulate the expression of proteins involved in cell maturation and lipid synthesis, offering a broad field of study on the homeostasis of the skin barrier and cellular responses to retinol derivatives.
Mechanism of action
Isotretinoin acts through the binding and activation of the nuclear receptors RAR and RXR, which function as transcription factors. This process inhibits the transcription of genes responsible for the lipogenic proliferation and differentiation of sebocytes, resulting in a reversible atrophy of the sebaceous glands. Likewise, it alters the dynamics of follicular keratinization, facilitating the unblocking of the pilosebaceous duct and reducing the bioavailability of substrate for the commensal microbiota correlated with inflammatory processes.
Mechanism summary
Agonist of RAR/RXR nuclear receptors that suppresses the activity of the sebaceous glands and modulates the differentiation of keratinocytes.
Clinical Studies (4)
- Oral isotretinoin for acne (Costa, et al. · The Cochrane Database of Systematic Reviews · 2018) PMID 30484286.
- Efficacy and adverse events of oral isotretinoin for acne: a systematic review (Vallerand, et al. · The British Journal of Dermatology · 2018) PMID 28542914.
- The use of isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects (Landis, et al. · Expert Review of Clinical Pharmacology · 2020) PMID 32744074.
- Acne Relapse and Isotretinoin Retrial in Patients With Acne (Lai J, et al. · JAMA Dermatology · 2025) PMID 39813053.
Warnings
Isotretinoin is a research-use-only (RUO) compound; the following warnings and handling considerations apply to its laboratory use:
- High teratogenic potential; its contact is prohibited in pregnant research models
- Requires strict monitoring of liver function and lipid profile
- Avoid deliberate exposure to UV radiation during the study period
- Severe hepatic or renal insufficiency in biological models
- Pre-existing hypervitaminosis A
- Concomitant administration with tetracyclines
- Pregnancy and lactation in animal models
Technical data
- CAS
- 4759-48-2
- Molecular formula
- C20H28O2
- Molecular weight
- 300.44 Da
- Compound type
- vitamin
- Storage
- 15-30°C, protect from light
- Shelf life (lyophilized)
- Not applicable (capsule/liquid presentation)
- Shelf life (reconstituted)
- 24 months in sealed original packaging
- Light-sensitive
- Sí
Frequently asked questions about Isotretinoin
What is Isotretinoin?
Systemic retinoid for research, classified as 13-cis-retinoic acid. It acts as an agonist of the nuclear receptors RAR and RXR, modulating sebaceous activity and cell differentiation.
What is the mechanism of action of Isotretinoin?
Agonist of RAR/RXR nuclear receptors that suppresses the activity of the sebaceous glands and modulates the differentiation of keratinocytes.
What is Isotretinoin researched for?
In preclinical research, Isotretinoin is studied mainly in: Reduction of sebaceous production in research models; Modulation of keratinocyte differentiation; Study of the inhibition of comedogenesis. Material exclusively for scientific research.
What are the chemical properties of Isotretinoin?
Molecular formula C20H28O2; molecular weight 300.44 Da; CAS number 4759-48-2.
How is Isotretinoin stored?
Storage conditions: 15-30°C, protect from light; lyophilized stability: Not applicable (capsule/liquid presentation); once reconstituted: 24 months in sealed original container; protect from light.
What routes of administration are studied for Isotretinoin?
In research models the following are described: Oral. Use is exclusively for scientific research.